The Evaluation and Treatment of Graves Ophthalmopathy

Marius N. Stan; James A. Garrity; Rebecca S. Bahn

doi:10.1016/j.mcna.2012.01.014

The Evaluation and Treatment of Graves Ophthalmopathy

Marius N. Stan, James A. Garrity, Rebecca S. Bahn

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Review article › peer-review

47 Scopus citations

Abstract

Optimum care of the patient with Graves ophthalmopathy (GO) is achieved through teamwork between the endocrinologist and ophthalmologist, with input from ancillary specialists as needed. Clinical evaluation should include determination of both the severity and the activity of the disease. It is important to assess early in the evaluation the impact of the disease on the patient's quality of life and their priorities and expectations regarding management. Once this information has been gathered, careful discussion between patient and physicians can define the management plan. This article reviews the pathophysiology, epidemiology, evaluation, and management of GO.

Original language	English (US)
Pages (from-to)	311-328
Number of pages	18
Journal	Medical Clinics of North America
Volume	96
Issue number	2
DOIs	https://doi.org/10.1016/j.mcna.2012.01.014
State	Published - Mar 2012

Keywords

Graves disease
Graves ophthalmopathy
Radioactive iodine
Thyrotropin receptor autoantibodies

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/j.mcna.2012.01.014

Cite this

@article{1bdda80f998743e385efda327b691487,

title = "The Evaluation and Treatment of Graves Ophthalmopathy",

abstract = "Optimum care of the patient with Graves ophthalmopathy (GO) is achieved through teamwork between the endocrinologist and ophthalmologist, with input from ancillary specialists as needed. Clinical evaluation should include determination of both the severity and the activity of the disease. It is important to assess early in the evaluation the impact of the disease on the patient's quality of life and their priorities and expectations regarding management. Once this information has been gathered, careful discussion between patient and physicians can define the management plan. This article reviews the pathophysiology, epidemiology, evaluation, and management of GO.",

keywords = "Graves disease, Graves ophthalmopathy, Radioactive iodine, Thyrotropin receptor autoantibodies",

author = "Stan, {Marius N.} and Garrity, {James A.} and Bahn, {Rebecca S.}",

year = "2012",

month = mar,

doi = "10.1016/j.mcna.2012.01.014",

language = "English (US)",

volume = "96",

pages = "311--328",

journal = "Medical Clinics of North America",

issn = "0025-7125",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - The Evaluation and Treatment of Graves Ophthalmopathy

AU - Stan, Marius N.

AU - Garrity, James A.

AU - Bahn, Rebecca S.

PY - 2012/3

Y1 - 2012/3

N2 - Optimum care of the patient with Graves ophthalmopathy (GO) is achieved through teamwork between the endocrinologist and ophthalmologist, with input from ancillary specialists as needed. Clinical evaluation should include determination of both the severity and the activity of the disease. It is important to assess early in the evaluation the impact of the disease on the patient's quality of life and their priorities and expectations regarding management. Once this information has been gathered, careful discussion between patient and physicians can define the management plan. This article reviews the pathophysiology, epidemiology, evaluation, and management of GO.

AB - Optimum care of the patient with Graves ophthalmopathy (GO) is achieved through teamwork between the endocrinologist and ophthalmologist, with input from ancillary specialists as needed. Clinical evaluation should include determination of both the severity and the activity of the disease. It is important to assess early in the evaluation the impact of the disease on the patient's quality of life and their priorities and expectations regarding management. Once this information has been gathered, careful discussion between patient and physicians can define the management plan. This article reviews the pathophysiology, epidemiology, evaluation, and management of GO.

KW - Graves disease

KW - Graves ophthalmopathy

KW - Radioactive iodine

KW - Thyrotropin receptor autoantibodies

UR - http://www.scopus.com/inward/record.url?scp=84858758074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858758074&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2012.01.014

DO - 10.1016/j.mcna.2012.01.014

M3 - Review article

C2 - 22443978

AN - SCOPUS:84858758074

SN - 0025-7125

VL - 96

SP - 311

EP - 328

JO - Medical Clinics of North America

JF - Medical Clinics of North America

IS - 2

ER -

The Evaluation and Treatment of Graves Ophthalmopathy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this